Longevity biotech market to exceed $31 billion by 2030
The market is projected to exceed $31 billion in 2030 with an 8% compound annual growth rate. North America is forecast to be the largest regional market at approximately $12 billion.
- Field
- business and funding
- What they did
- Researchers project the longevity biotech market will exceed $31 billion by 2030, growing at an 8% compound annual growth rate.
- Why it matters
- This will help understand how fast investments are growing in companies focused on biological age testing and preventive health programs.
#longevity biotech#market forecast#anti-senescence



